Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.27, $1.12 worse than the analyst estimate of $5.39. Revenue for the quarter came in at $618.8 million versus the consensus estimate of $650.6 million.

GUIDANCE:

Chemed Corporation sees FY2025 EPS of $22.00-$22.30, versus the consensus of $23.29.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.